BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23702658)

  • 1. Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report.
    Rotllan N; Ramírez CM; Aryal B; Esau CC; Fernández-Hernando C
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1973-7. PubMed ID: 23702658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of miR-148a attenuates atherosclerosis progression in APOB
    Rotllan N; Zhang X; Canfrán-Duque A; Goedeke L; Griñán R; Ramírez CM; Suárez Y; Fernández-Hernando C
    Biomed Pharmacother; 2022 Sep; 153():113419. PubMed ID: 36076541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs in lipoprotein metabolism and cardiometabolic disorders.
    Rotllan N; Price N; Pati P; Goedeke L; Fernández-Hernando C
    Atherosclerosis; 2016 Mar; 246():352-60. PubMed ID: 26828754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
    Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Marquart TJ; Wu J; Lusis AJ; Baldán Á
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):455-8. PubMed ID: 23288159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.
    Rayner KJ; Sheedy FJ; Esau CC; Hussain FN; Temel RE; Parathath S; van Gils JM; Rayner AJ; Chang AN; Suarez Y; Fernandez-Hernando C; Fisher EA; Moore KJ
    J Clin Invest; 2011 Jul; 121(7):2921-31. PubMed ID: 21646721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the Mir-106b~ 25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice.
    Semo J; Chernin G; Jonas M; Shimoni S; George J
    Lipids Health Dis; 2019 Dec; 18(1):208. PubMed ID: 31796057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice.
    Horie T; Baba O; Kuwabara Y; Chujo Y; Watanabe S; Kinoshita M; Horiguchi M; Nakamura T; Chonabayashi K; Hishizawa M; Hasegawa K; Kume N; Yokode M; Kita T; Kimura T; Ono K
    J Am Heart Assoc; 2012 Dec; 1(6):e003376. PubMed ID: 23316322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice.
    Sala F; Aranda JF; Rotllan N; Ramírez CM; Aryal B; Elia L; Condorelli G; Catapano AL; Fernández-Hernando C; Norata GD
    Thromb Haemost; 2014 Oct; 112(4):796-802. PubMed ID: 25008143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies.
    Van Craeyveld E; Gordts SC; Nefyodova E; Jacobs F; De Geest B
    J Mol Med (Berl); 2011 Jun; 89(6):555-67. PubMed ID: 21249329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-144 Silencing Protects Against Atherosclerosis in Male, but Not Female Mice.
    Cheng J; Cheng A; Clifford BL; Wu X; Hedin U; Maegdefessel L; Pamir N; Sallam T; Tarling EJ; de Aguiar Vallim TQ
    Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):412-425. PubMed ID: 31852219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis.
    Price NL; Rotllan N; Canfrán-Duque A; Zhang X; Pati P; Arias N; Moen J; Mayr M; Ford DA; Baldán Á; Suárez Y; Fernández-Hernando C
    Cell Rep; 2017 Oct; 21(5):1317-1330. PubMed ID: 29091769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice.
    Goedeke L; Rotllan N; Ramírez CM; Aranda JF; Canfrán-Duque A; Araldi E; Fernández-Hernando A; Langhi C; de Cabo R; Baldán Á; Suárez Y; Fernández-Hernando C
    Atherosclerosis; 2015 Dec; 243(2):499-509. PubMed ID: 26520906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice.
    Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA
    PLoS One; 2015; 10(6):e0128996. PubMed ID: 26046657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
    Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
    Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-24 aggravates atherosclerosis by inhibiting selective lipid uptake from HDL cholesterol via the post-transcriptional repression of scavenger receptor class B type I.
    Ren K; Zhu X; Zheng Z; Mo ZC; Peng XS; Zeng YZ; Ou HX; Zhang QH; Qi HZ; Zhao GJ; Yi GH
    Atherosclerosis; 2018 Mar; 270():57-67. PubMed ID: 29407889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.
    Ouimet M; Ediriweera H; Afonso MS; Ramkhelawon B; Singaravelu R; Liao X; Bandler RC; Rahman K; Fisher EA; Rayner KJ; Pezacki JP; Tabas I; Moore KJ
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1058-1067. PubMed ID: 28428217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1.
    Lv YC; Tang YY; Peng J; Zhao GJ; Yang J; Yao F; Ouyang XP; He PP; Xie W; Tan YL; Zhang M; Liu D; Tang DP; Cayabyab FS; Zheng XL; Zhang DW; Tian GP; Tang CK
    Atherosclerosis; 2014 Sep; 236(1):215-26. PubMed ID: 25084135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice.
    Shih DM; Shaposhnik Z; Meng Y; Rosales M; Wang X; Wu J; Ratiner B; Zadini F; Zadini G; Lusis AJ
    FASEB J; 2013 Sep; 27(9):3805-17. PubMed ID: 23752203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.